Preserved central nervous system functioning after use of romidepsin as a latency-reversing agent in an HIV cure strategy

Autor: Muñoz Moreno, Jose Antonio, Carrillo Molina, Sara, Martínez Zalacaín, Ignacio, Miranda, Cristina, Manzardo, Christian, Coll, Pep, Meulbroek, Michael, Hanke, Tomáš, Garolera, Maite, Miró, Josep M., Brander, Christian, Clotet, Bonaventura, Soriano Mas, Carles, Moltó, José, Mothe, Beatriz, BCN02-Neuro Substudy Group

Publikováno v: AIDS
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
O2, repositorio institucional de la UOC
Universitat Oberta de Catalunya (UOC)

Objective: To assess the central nervous system (CNS) impact of a kick&kill HIV cure strategy using therapeutic vaccine MVA.HIVconsv and the histone deacetylase inhibitor (HDACi) romidepsin (RMD) as latency-reversing agent. Design: Neurological obser

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c9f44d733191cb2b320346b9147fb543
https://fundanet.igtp.cat/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=6973